Armistice Capital’s Seagen Inc. Common Stock SGEN Stock Holding History

Armistice Capital’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-32,000	Closed	-$6.16M	–	298
2023 Q2	$6.16M	Buy	+32,000	New	+$6.36M	0.09%	111

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Armistice Capital's SGEN Position: Q3 2023 in Review

Armistice Capital sold out of Seagen Inc. Common Stock (SGEN) in Q3 2023, closing a stake of 32,000 shares — an estimated $6.16M sold.

Armistice Capital first reported a position in SGEN in Q2 2023 and held it in 1 quarter. The position peaked at $6.16M in Q2 2023. 616 funds tracked by Wall St. Rank hold SGEN as of Q3 2023.

Armistice Capital reported no remaining Seagen Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Armistice Capital sold 32,000 Seagen Inc. Common Stock shares in Q3 2023, an estimated $6.16M.
Armistice Capital first reported a position in Seagen Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Armistice Capital's Seagen Inc. Common Stock position peaked at $6.16M in Q2 2023.
616 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2023.

Based on Armistice Capital's 13F filing for Q3 2023, filed 14 Nov 2023.